Zimmer Biomet Holdings, Inc. (ZBH) To Go Ex-Dividend on September 30th

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) declared a quarterly dividend on Friday, August 28th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.24 per share by the medical equipment provider on Friday, October 30th. This represents a $0.96 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend is Wednesday, September 30th.

Zimmer Biomet has a dividend payout ratio of 11.5% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Zimmer Biomet to earn $8.99 per share next year, which means the company should continue to be able to cover its $0.96 annual dividend with an expected future payout ratio of 10.7%.

Get Zimmer Biomet alerts:

Zimmer Biomet Trading Up 0.0%

NYSE:ZBH opened at $91.08 on Monday. The company has a 50-day moving average price of $96.23 and a 200-day moving average price of $91.25. The stock has a market cap of $17.37 billion, a price-to-earnings ratio of 22.16, a P/E/G ratio of 1.72 and a beta of 0.47. The company has a current ratio of 1.69, a quick ratio of 0.94 and a debt-to-equity ratio of 0.50. Zimmer Biomet has a 12 month low of $79.12 and a 12 month high of $106.88.

Zimmer Biomet (NYSE:ZBH – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The medical equipment provider reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.01 by $0.06. Zimmer Biomet had a net margin of 9.48% and a return on equity of 13.12%. The company had revenue of $2.18 billion for the quarter, compared to analysts’ expectations of $2.13 billion. During the same quarter in the previous year, the company earned $2.07 earnings per share. Zimmer Biomet’s quarterly revenue was up 4.8% on a year-over-year basis. Zimmer Biomet has set its FY 2026 guidance at 8.470-8.590 EPS. Equities analysts predict that Zimmer Biomet will post 8.54 EPS for the current year.

About Zimmer Biomet

(Get Free Report)

Zimmer Biomet Holdings, Inc (NYSE:ZBH) is a medical technology company that develops, manufactures and markets products designed to treat musculoskeletal conditions. Its portfolio includes orthopedic implants and related systems for hip, knee, shoulder and other joint replacements, as well as products used in sports medicine, extremity care and trauma procedures.

The company also provides robotic- and computer-assisted surgical technologies, digital solutions and other tools intended to support orthopedic procedures and patient care.

Recommended Stories

• Five stocks we like better than Zimmer Biomet
• Fertilizer Prices Keep Climbing: 3 Stocks Still Trading at a Discount
• Why 3 Struggling Stocks Are Suddenly Spending Big on Buybacks
• 3 Niche Growth Stocks With an Edge Their Rivals Can’t Ignore
• 3 Dividend Stocks With Higher Yields and Room for More Payout Growth

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.